Barinthus Biotherapeutics

NASDAQ: BRNS · Real-Time Price · USD
1.26
-0.02 (-1.25%)
At close: Aug 15, 2025, 3:59 PM
1.30
3.58%
After-hours: Aug 15, 2025, 05:41 PM EDT

Barinthus Biotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
14.97M 802K 44.7M 268K
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
9.17M -4.64M 44.7M 268K
Operating Income
-67.97M -83.91M -4.04M -45.22M
Interest Income
2.68M 2.88M 3.1M 2K
Pretax Income
-61.23M -76.52M 850K -51.14M
Net Income
-61.07M -73.35M 5.34M -50.87M
Selling & General & Admin
29.67M 39.84M 6.39M 25.12M
Research & Development
38.25M 41.41M 41.11M 16.37M
Other Expenses
15.02M 3.46M 567K 4M
Operating Expenses
82.94M 84.72M 48.74M 45.49M
Interest Expense
53K 28K 19K 2.67M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
82.94M 84.72M 48.74M 45.49M
Income Tax Expense
-44K -3.08M -4.47M -28K
Shares Outstanding (Basic)
39.35M 38.39M 37.25M 37.19M
Shares Outstanding (Diluted)
39.35M 38.39M 38.17M 37.19M
EPS (Basic)
-1.55 -1.91 0.14 -1.37
EPS (Diluted)
-1.55 -1.91 0.14 -1.37
EBITDA
-55.37M -71.06M 6.4M -47.87M
EBIT
-61.17M -76.49M 869K -48.47M
Depreciation & Amortization
5.8M 5.45M 4.32M 601.93K